Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046722 · ClinicalTrials.gov registry record · Phase 1
Marijuana for HIV-Related Peripheral Neuropathy
A Phase 1 study of HIV Infections and Peripheral Nervous System Diseases, sponsored by Center for Medicinal Cannabis Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00046722: Completed Phase 1 study of HIV Infections and Peripheral Nervous System Diseases, sponsored by Center for Medicinal Cannabis Research.
NCT00046722 is a Phase 1 study of HIV Infections and Peripheral Nervous System Diseases that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 50 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00046722, a Phase 1 study of HIV Infections and Peripheral Nervous System Diseases, has completed, sponsored by Center for Medicinal Cannabis Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.
Conditions Studied
Interventions
- DRUG Smoked Marijuana
Study Locations (1)
California
- University of California, San Francisco Community Consortium - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-01 |
| Est. Completion | 2005-04 |
| Phase | Phase 1 |
What the finished NCT00046722 record still lists
NCT00046722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Smoked Marijuana is the first listed.
NCT00046722 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00046722 about?
NCT00046722 is a clinical study titled "Marijuana for HIV-Related Peripheral Neuropathy". To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.
What is the current status of trial NCT00046722?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2003-01. Estimated completion is 2005-04.
What conditions does trial NCT00046722 study?
This clinical trial studies the following conditions: HIV Infections, Peripheral Nervous System Diseases.
What interventions are being tested in trial NCT00046722?
The interventions under investigation include: Smoked Marijuana (DRUG).
Who is sponsoring clinical trial NCT00046722?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00046722 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00046722's enrollment target sits among peer trials
50 355th of 542 higher than 177 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia